CN106689358A - Infant formula food for special medical purposes - Google Patents

Infant formula food for special medical purposes Download PDF

Info

Publication number
CN106689358A
CN106689358A CN201611004079.0A CN201611004079A CN106689358A CN 106689358 A CN106689358 A CN 106689358A CN 201611004079 A CN201611004079 A CN 201611004079A CN 106689358 A CN106689358 A CN 106689358A
Authority
CN
China
Prior art keywords
lactose
infant formula
vitamin
lactase
formula food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611004079.0A
Other languages
Chinese (zh)
Inventor
徐詹程
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611004079.0A priority Critical patent/CN106689358A/en
Publication of CN106689358A publication Critical patent/CN106689358A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1206Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins

Abstract

The invention discloses an infant formula food for special medical purposes. The infant formula food does not contain lactose and contains lactase, and particularly lactose-free milk powder added with the lactase is used as a raw material. According to the infant formula food disclosed by the invention, the convention that lactose intolerance is relieved by removing lactose from baby foods usually is broken, and a certain content of the lactase is added to the milk powder free from the lactose, and then the infant formula food for special medical purposes, conforming to regulations of GB25596-2010 of National Standard is prepared. Before eating normal lactose-containing foods or eating the normal lactose-containing foods and the infant formula food at the same time, babies can prevent lactose intolerance. The infant formula food disclosed by the invention is safe to eat, free from any adverse effects and safe, and can meet growth and development requirements of the babies.

Description

A kind of special medicine purposes infant formula
Technical field
The invention belongs to baby food technical field, and in particular to a kind of special medicine purposes infant formula.
Background technology
Breast milk, formula milk are the main food sources of baby, and lactose contained therein provides 20% energy, also participates in brain Developmental process, promote trace element absorption, played an important role in infants growth and development.However, according to medical statistics, Baby's lactose malabsorption and the illness of lactose intolerance with the presence of up to 40%, can draw after its edible food containing lactose Noninfectious diarrhea is played, influence baby's grows, and this belongs to baby's lactose digestion disease of primary.Also Secondary cases Baby's lactose malabsorption disease, the infantile diarrhea that exactly any cause of disease causes, convalescence intestinal villi top brush border is damaged Lactase cannot be secreted, it is necessary to supplement lactase nursing(Or fed using lactose-free formula milk, such breast milk baby will change Feeding patterns), will otherwise aggravate the state of an illness.
For lactose malabsorption and lactose intolerance, mainly alleviated with lactose enzyme product on Vehicles Collected from Market, these Lactose enzyme product includes solid beverage, pressed candy etc., and main formula composition is covered:Lactase, DEXTROSE ANHYDROUS, stachyose, Apple powder, maltodextrin, polydextrose, FOS, galactooligosaccharide, concentrated whey protein powder, desalted whey powder, bifid bar Bacterium, magnesia, edible glucose, dicalcium phosphate, edible gelatin, pigment(Gelatin is only existed in capsule adventitia with pigment)Deng, All belong to ordinary food.Although all containing a certain amount of lactase, human body can be helped to realize the effect for reducing lactose after taking, May not apply to one-year-old following consumption by infants(GB GB25596-2010 specify).But because market surpervision is not tight, these Lactose enzyme product still circulates in baby food in the market, because it does not meet baby food trophic structure demand, it is clear that can be right Growing for baby brings certain influence.
One-year-old following baby alleviates lactose intolerance and lactose malabsorption is mainly edible lactose-free breast system Product, but lactose plays indispensable effect to the growth and development of baby again, lactose-free food is eaten for a long time necessarily right The growth of baby produces influence.
The content of the invention
For the above state of the art, it is an object of the invention to provide a kind of special medicine purposes infant formula, it is used for Intervene and treatment less than 1 years old lactose intolerance and lactose malabsorption of baby, and to infants growth and development without any bad Influence.
The present invention is adopted the following technical scheme that:
A kind of special medicine purposes infant formula, it does not include lactose, and contains lactase.
Specifically, the special medicine purposes infant formula is to use the lactose-free milk powder for being added with lactase as original Material.
Preferably, the mass content of lactase is 3-5% in the special medicine purposes infant formula.
Preferably, described infant formula includes following component per 100g:Containing lactase 4.5g by agalasisa Fresh milk the powder 37.8g, composite mineral matter 1.87g, B B-complex 99.98mg, galactooligosaccharide 1.13g, glucose of sugar treatment Polymer 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, the mg of taurine 32.9, the mg of VBT 8.3, nucleosides 15 mg of acid.
Preferably, composition of the described infant formula per 100g can also be:Containing lactase 4.5g by agalasisa Fresh milk the powder 38.89g, composite mineral matter 1.87g, B B-complex 99.98mg of sugar treatment, the microgram of lutein 11, beta carotene 7 micrograms, glucose polymer 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, the mg of taurine 32.9, VBT 8.3 mg, the mg of nucleotides 15.
The composite mineral matter includes following element:Na 170 mg, K 600mg, Cl 375mg, Ca 420mg, P The 70 127 12.8 μ g of μ g, Se of μ g, Mn of μ g, Zn 4.1mg, I of 245mg, Mg 50mg, Fe 5.6mg, Cu 390.
The B B-complex includes the microgram of vitamin A 535, the microgram of vitamin D 6.7,0.5 milligram of vitamin E, dimension Raw element K138.2 micrograms, 87.3 milligrams of vitamin C, vitamin B10.5 milligram, vitamin B20.55 milligram, 5 milligrams of nicotinic acid, Vitamin B6 0.35 milligram, 5.2 milligrams of pantothenic acid, vitamin B121.4 micrograms.
The positive effect of the present invention is as follows:The present invention has broken baby food generally alleviates lactose intolerance to remove lactose By the convention of disease, selection adds the lactase of certain content in lactose-free milk powder, then is prepared into and meets GB The special medicine purposes infant formula of GB25596-2010 regulation, baby is on the feed before normal lactase-containing comestibles or same When eat food of the present invention, you can avoid the generation of lactose intolerance, and edible safety of the present invention, there is no any bad work With the need for being fully able to meet infants growth and development.
The present invention has filled up the blank of the special lactose enzyme product of baby, to baby on the premise of correlation standard is met Lactose intolerance and lactose malabsorption carry out therapeutic intervention, and its trophic structure is best suitable for the demand of growing of baby, right Baby does not have any harmful effect, and long-term consumption can be trusted completely, with significant social and economic benefit.
Specific embodiment
Technical scheme is described in detail with specific embodiment below.
Embodiment 1
A kind of special medicine purposes baby's special food, including following components:Containing lactase 4.5g by lactose-free treatment Fresh milk powder 37.8g, composite mineral matter 1.87g, B B-complex 99.98mg, galactooligosaccharide 1.13g, glucose polymer 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, the mg of taurine 32.9, the mg of VBT 8.3, nucleotides 15 mg.Following element wherein in composite mineral matter:Na 170 mg, K 600mg, Cl 375mg, Ca 420mg, P 245mg, Mg The 70 127 12.8 μ g of μ g, Se of μ g, Mn of μ g, Zn 4.1mg, I of 50mg, Fe 5.6mg, Cu 390.Wherein B B-complex includes: The microgram of vitamin A 535, the microgram of vitamin D 6.7,0.5 milligram of vitamin E, vitamin K138.2 micrograms, vitamin C 87.3 milligrams, vitamin B10.5 milligram, vitamin B20.55 milligram, 5 milligrams of nicotinic acid, vitamin B6 0.35 milligram, pantothenic acid 5.2 milligrams, vitamin B121.4 micrograms.
Embodiment 2
A kind of special medicine purposes baby's special food, including following components:Containing lactase 4.5g by lactose-free treatment Fresh milk powder 38.89g, composite mineral matter 1.87g, B B-complex 99.98mg, the microgram of lutein 11, the microgram of beta carotene 7, Portugal Grape glycopolymers 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, the mg of taurine 32.9, the mg of VBT 8.3, The mg of nucleotides 15.Wherein composite mineral matter includes following element:Na 170 mg, K 600mg, Cl 375mg, Ca 420mg, The 70 127 12.8 μ g of μ g, Se of μ g, Mn of μ g, Zn 4.1mg, I of P 245mg, Mg 50mg, Fe 5.6mg, Cu 390.Wherein it is combined Vitamin includes:The microgram of vitamin A 535, the microgram of vitamin D 6.7,0.5 milligram of vitamin E, vitamin K138.2 micrograms, 87.3 milligrams of vitamin C, vitamin B10.5 milligram, vitamin B20.55 milligram, 5 milligrams of nicotinic acid, vitamin B6 0.35 milli Gram, 5.2 milligrams of pantothenic acid, vitamin B121.4 micrograms.
Effect test
1st, 2 month infant 120 of lactose malabsorption is chosen, there was no significant difference for height and weight, is randomly divided into two groups, every group 60 people, are breast-feeding.Experimental group first takes the infant formula 2g of the embodiment of the present invention 1 before lactation, is rushed with 14ml warm water Be taken after being infused in hot water or decoction use, then breast nursing again, if breast nursing interval is no more than 3 hours twice, food of the present invention can be no longer fed, if it is small to be spaced 3 When more than, then press again preceding method feed food of the present invention.Control group first feeds German import lactase capsule before lactation(Containing 17% Lactase, dicalcium phosphate, edible gelatin, pigment(Gelatin is only existed in capsule adventitia with pigment), dicalcium phosphate), by one Grain lactase capsule is broken into two with one's hands, and particle is poured into spoon, is fed after heating water dissolves, then breast nursing again, if breast nursing interval twice No more than 3 hours, product can be no longer fed, if being spaced more than 3 hours, then press preceding method hello product.
Two groups of baby's situations are counted after 30 days, experimental group and control group baby are without symptom of diarrhea, experimental group average height Increase 2.7cm, average weight increases 0.78kg, and mean head increases 1.4cm, and control group average height increases 2.3cm, average body Increase 0.71kg again, mean head increases 1.1cm.It can be seen that edible infant formula of the present invention can ensure the normal growth of baby Development, and baby is eating period without any ill symptomses, number of times considerably less than control group of crying and screaming.
2nd, 4 month infant of Secondary cases lactose intolerance 96 is chosen, there was no significant difference for height and weight, the course of disease 1 day, abdomen Rush down number of times to be all higher than 10 times, and be watery stool, be randomly divided into two groups, every group of 48 people, using same formula milk containing lactose Powder is fed, and experimental group adds the formula food 2g of the embodiment of the present invention 2 when feeding in the formula milk for reconstituting, if feeding twice Support interval to be no more than 3 hours, then can no longer add food of the present invention, if being spaced more than 3 hours, the present invention is fed food by preceding method Product.Control group is with certain domestic lactase solid beverage(Dispensing includes apple powder, maltodextrin, polydextrose, FOS, breast Carbohydrase, galactooligosaccharide), instead of food of the present invention, remaining is identical with experimental group.
After experimental group Infants'feeding one day, diarrhoea number of times is dropped to less than 3 times, and control group Infants'feeding is suffered from diarrhoea after one day It is 39 people that number of times drops to less than 3 times, is down to two days later less than 3 times, chooses in two groups of babies day diarrhoea number of times after a day It is down to less than 3 times, continues to feed foregoing formula milk containing lactose, watery stool diarrhoea occurs again, experimental group is 3 people, Account for experiment number(48 people)6.25%, control group be 3 people, account for experiment number(39 people)7.69%.
From above effect test, infant formula comprehensive nutrition of the present invention, rationally, the lactase compared with the market is produced Product are more suitable for the growth and development of baby, for Secondary cases lactose intolerance effect more preferably, and comply fully with relevant criterion and The requirement of regulation, with wide market prospects.

Claims (7)

1. a kind of special medicine purposes infant formula, it is characterised in that:It does not include lactose, and contains lactase.
2. infant formula according to claim 1, it is characterised in that:It is with the lactose-free milk for being added with lactase Powder is used as raw material.
3. infant formula according to claim 1 and 2, it is characterised in that:Wherein the mass content of lactase is 3- 5%。
4. infant formula according to claim 3, it is characterised in that:Include following component per 100g:Containing lactose The fresh milk powder 37.8g by lactose-free treatment of enzyme 4.5g, composite mineral matter 1.87g, B B-complex 99.98mg, oligomeric half Lactose 1.13g, glucose polymer 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, taurine 32.9 mg, L- The mg of carnitine 8.3, the mg of nucleotides 15.
5. infant formula according to claim 3, it is characterised in that:Component including following weight portion:Containing lactose Fresh milk the powder 38.89g, composite mineral matter 1.87g, B B-complex 99.98mg, lutein by lactose-free treatment of enzyme 4.5g 11 micrograms, the microgram of beta carotene 7, glucose polymer 59g, biotin 11.4 μ g, the mg of choline 50, the mg of inositol 3.57, ox sulphur Acid 32.9 mg, the mg of VBT 8.3, the mg of nucleotides 15.
6. the infant formula according to claim 4 or 5, it is characterised in that:The composite mineral matter includes following Element:Na 170 mg, K 600mg, Cl 375mg, Ca 420mg, P 245mg, Mg 50mg, Fe 5.6mg, Cu 390 μ g, Zn The 127 12.8 μ g of μ g, Se of μ g, Mn of 4.1mg, I 70.
7. the infant formula according to claim 4 or 5, it is characterised in that:The B B-complex includes vitamin A 535 micrograms, the microgram of vitamin D 6.7,0.5 milligram of vitamin E, vitamin K138.2 micrograms, 87.3 milligrams of vitamin C, dimension Raw element B10.5 milligram, vitamin B20.55 milligram, 5 milligrams of nicotinic acid, vitamin B6 0.35 milligram, 5.2 milligrams of pantothenic acid, dimension life Plain B121.4 micrograms.
CN201611004079.0A 2016-11-15 2016-11-15 Infant formula food for special medical purposes Pending CN106689358A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611004079.0A CN106689358A (en) 2016-11-15 2016-11-15 Infant formula food for special medical purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611004079.0A CN106689358A (en) 2016-11-15 2016-11-15 Infant formula food for special medical purposes

Publications (1)

Publication Number Publication Date
CN106689358A true CN106689358A (en) 2017-05-24

Family

ID=58940745

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611004079.0A Pending CN106689358A (en) 2016-11-15 2016-11-15 Infant formula food for special medical purposes

Country Status (1)

Country Link
CN (1) CN106689358A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101233876A (en) * 2008-02-02 2008-08-06 内蒙古蒙牛乳业(集团)股份有限公司 Low lactose liquid state milk suitable for baby from 0 to 12 months old
CN101511199A (en) * 2006-09-05 2009-08-19 麦克内尔营养有限公司 Lactase-containing comestibles and related methods
GB2481169A (en) * 2009-04-15 2011-12-14 Bopa Ireland Ltd A reduced lactose milk product and a process for the preparation thereof
CN105831253A (en) * 2016-03-23 2016-08-10 无锡超科食品科技有限公司 Lactose-free infant formula milk powder and preparation method thereof
CN106061293A (en) * 2014-03-05 2016-10-26 帝斯曼知识产权资产管理有限公司 Liquid lactase compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101511199A (en) * 2006-09-05 2009-08-19 麦克内尔营养有限公司 Lactase-containing comestibles and related methods
CN101233876A (en) * 2008-02-02 2008-08-06 内蒙古蒙牛乳业(集团)股份有限公司 Low lactose liquid state milk suitable for baby from 0 to 12 months old
GB2481169A (en) * 2009-04-15 2011-12-14 Bopa Ireland Ltd A reduced lactose milk product and a process for the preparation thereof
CN106061293A (en) * 2014-03-05 2016-10-26 帝斯曼知识产权资产管理有限公司 Liquid lactase compositions
CN105831253A (en) * 2016-03-23 2016-08-10 无锡超科食品科技有限公司 Lactose-free infant formula milk powder and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中华人民共和国卫生部: "食品安全国家标准 特殊医学用途婴儿配方食品通则", 《食品安全国家标准 特殊医学用途婴儿配方食品通则 *
孙俊等: "无乳糖配方粉的研究进展及应用", 《食品安全导刊》 *

Similar Documents

Publication Publication Date Title
CN101123888B (en) Oligosaccharide mixture
CN101278688A (en) Infant nutrition immunity formula milk powder and method of preparing the same
CN101971951B (en) Yam flour with healthcare function and preparation method
CN110754530A (en) Formula milk powder capable of effectively promoting height development of children and production method thereof
WO2011091623A1 (en) Functional nutriment with effects of promoting lactation and recovery for postpartum women and its preparation methods
CN101836676B (en) Soy-based milk powder and preparation method thereof
CN103070241A (en) Infant-formula goat milk powder of pure goat milk protein and preparation method thereof
CN110122865B (en) Infant auxiliary food added with breast milk oligosaccharide and preparation method thereof
CN111543496A (en) Milk powder for helping children to grow in height and skeleton
CN113412862A (en) Formula milk powder for middle-aged and old people and preparation method thereof
CN103070242A (en) Formula goat milk powder for pregnant women and preparation method of formula goat milk powder
CN113412861A (en) Formula growth milk powder for children and preparation method thereof
CN102379345A (en) Modified milk suitable for pregnant woman and production technique thereof
CN108771072A (en) A kind of probiotic composition and infant's probiotics solid beverage
CN101176553A (en) Fresh fruit konjak functional food and preparation method thereof
CN112385843A (en) Balanced nutrition powder containing composite prebiotics and preparation method thereof
CN101904362B (en) Soy-based infant powder and preparation method thereof
CN113396983A (en) Child modified milk powder rich in comprehensive nutrition and preparation method thereof
CN111642566A (en) Goat milk powder beneficial to children's height and intelligence development
CN106689358A (en) Infant formula food for special medical purposes
CN1041791C (en) Infant breast milk powder and prodn. method
CN101422240A (en) Human milk(containing first milk) freeze-drying powder production technique and products and use thereof
CN112868803A (en) Formula milk powder for improving breast milk nutrition and preparation method thereof
CN113678897A (en) Formula milk powder for promoting nutrient absorption of pregnant and lying-in women and preparation method thereof
CN113170880A (en) Bird's nest peptide pregnant woman bird's nest and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170524